21 firms give Smith & Nephew 'hold' rating

Spinal Tech

Smith & Nephew earned a "hold" rating average from 21 firms covering the stock, according to the Mideast Times.

There are eight firms with a "buy" rating and three analysts with a "sell" rating. There is a one-year price target of $16.75, according to the report.


JPMorgan Chase & Co., reiterated the "neutral" rating with a price target at $14.67 earlier this week. Last week, Beaufort Securities reiterated the "sell" rating.


This past Monday, Smith & Nephew's Julie Brown sold 4,227 shares on the open market at $17 per share for a total transaction reaching $71,869.19.


Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers